INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo LUMIGAN® 0,03% Eye drops

SCHEDULING STATUS
Schedule 4

PROPRIETARY NAME
(and dosage form)

LUMIGAN® 0,03% Eye drops

COMPOSITION
Each mL of sterile solution contained
bimatoprost 0,3 mg.

PHARMACOLOGICAL CLASSIFICATION
A. 15.4 Ophthalmological preparations. Others

Removed from this site: June 2018
Advised by: Pharmaceutical Industry

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2017